Article Text

Download PDFPDF
Modulation of fasciculation frequency in amyotrophic lateral sclerosis
  1. Mamede de Carvalho1,2,
  2. Antonia Turkman3,
  3. Susana Pinto1,
  4. Michael Swash1,4
  1. 1 Translational Clinical Physiology Unit, Faculty of Medicine, Instituto de Medicina Molecular and Institute of Physiology, University of Lisbon, Lisbon, Portugal
  2. 2 Department of Neurosciences, Hospital de Santa Maria, Lisbon, Portugal
  3. 3 Faculty of Sciences, Centro de Estatística e Aplicaçōes, University of Lisbon, Lisbon, Portugal
  4. 4 Departments of Neurology and Neuroscience, Royal London Hospital, Queen Mary University of London, London, UK
  1. Correspondence to : Professor Mamede de Carvalho, Department of Neurosciences, Hospital de Santa Maria, Av Professor Egas Moniz, Lisbon 1648-028, Portugal; mamedemg{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Fasciculations are a major clinical feature, present very early in the natural history of amyotrophic lateral sclerosis (ALS).1 They represent spontaneous discharges of motor units or portions of motor units, that can sometimes also be activated volitionally.2 There is no objective evidence that fasciculation potential (FP) discharges can be modulated by the patient or by the examiner. In this study we have addressed this issue in ALS, spinal muscular atrophy (SMA) and benign fasciculation syndrome (BFS).


We evaluated fasciculation firing frequency, using surface electromyographic (EMG) recordings from the first dorsal interosseous (DI) muscle in the hand at rest, and randomly after a period of maximal contraction, thus involving upper and lower motor neuron excitation, after radial sensory nerve stimulation and after supramaximal electrical stimulation of the ulnar nerve at the wrist, representing lower motor neuron excitation. We studied 75 patients with definite or probable ALS, excluding patients with polyneuropathy, diabetes or ulnar neuropathy (median age 61 years (range 27–75 years), median disease duration 12 months (range 3–24 months), 48 were men). One hand, in which first DI strength was 4 on the MRC (Medical Research Council) score 4 or 5, was studied in each patient. In each participant, FPs were recorded at rest in the first DI muscle. Six patients with SMA type 3 were studied (median age 45 years; range 28–60 years). …

View Full Text


  • Contributors All authors have contributed to this paper. MdC was involved in study design, neurophysiological investigation and draft preparation. AT was involved in statistical analysis. SP was involved in patient recruitment and clinical follow-up. MS was involved in study design, data discussion and writing.

  • Funding This work was partially funded by the SOPHIA project funded by JPND and by “Fundação para a Ciência e Tecnologia” (JPND/0002/2011).

  • Competing interests None.

  • Patient consent Obtained.

  • Ethics approval This protocol was approved by the Centro Hospitalar Lisboa Norte Ethics Commission.

  • Provenance and peer review Not commissioned; externally peer reviewed.